Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-20-003710
Filing Date
2020-03-11
Accepted
2020-03-11 14:50:59
Documents
6
Effectiveness Date
2020-03-11

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 81679
2 ex5-1.htm EX-5.1 26496
3 ex23-1.htm EX-23.1 5659
4 ex23-1_001.jpg GRAPHIC 22792
5 ex23-1_002.jpg GRAPHIC 31908
6 ex5-1_001.jpg GRAPHIC 3786
  Complete submission text file 0001493152-20-003710.txt   196037
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237081 | Film No.: 20705040
SIC: 7389 Services-Business Services, NEC